Source:http://linkedlifedata.com/resource/pubmed/id/19301682
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2009-3-23
|
pubmed:abstractText |
In vivo preclinical assays are required to screen potential agents that target the tumor vasculature. Here, a hollow fibre-based assay for the quantification of neovasculature in the presence or absence of an agent that potentially targets tumor neovasculature is described. The neovasculature is developed as a consequence of the presence of tumor cells encapsulated in hollow fibres, which are transplanted subcutaneously in the dorsal flanks of mice.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1064-3745
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
467
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
331-42
|
pubmed:meshHeading |
pubmed-meshheading:19301682-Animals,
pubmed-meshheading:19301682-Biological Assay,
pubmed-meshheading:19301682-Cell Line, Tumor,
pubmed-meshheading:19301682-Mice,
pubmed-meshheading:19301682-Neoplasms,
pubmed-meshheading:19301682-Neovascularization, Pathologic,
pubmed-meshheading:19301682-Prostheses and Implants,
pubmed-meshheading:19301682-Tissue Culture Techniques
|
pubmed:year |
2009
|
pubmed:articleTitle |
Use of the hollow fibre assay for studies of tumor neovasculature.
|
pubmed:affiliation |
Institute of Cancer Therapeutics, University of Bradford, Bradford, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|